Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

BACKGROUND: Retinopathy of prematurity (ROP) is one of the common complications of prematurity. Intravitreal injection of ranibizumab (IVR), an antivascular endothelial growth factor (VEGF) drug, showed significant benefit for ROP. However, there are concerns about systemic complications of anti-VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuting, Zhou, Lin, Zhang, Qi, Xu, Yu, Zhao, Peiquan, Xia, Hongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545787/
https://www.ncbi.nlm.nih.gov/pubmed/31236289
http://dx.doi.org/10.1155/2019/2985161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545787/
https://www.ncbi.nlm.nih.gov/pubmed/31236289
http://dx.doi.org/10.1155/2019/2985161

Ejemplares similares